Lisa M. Walter
Interventions Targeting Glucocorticoid-Krüppel-like Factor 15-Branched-Chain Amino Acid Signaling Improve Disease Phenotypes in Spinal Muscular Atrophy Mice
Walter, Lisa M.; Deguise, Marc-Olivier; Meijboom, Katharina E.; Betts, Corinne A.; Ahlskog, Nina; van Westering, Tirsa L.E.; Hazell, Gareth; McFall, Emily; Kordala, Anna; Hammond, Suzan M.; Abendroth, Frank; Murray, Lyndsay M.; Shorrock, Hannah K.; Prosdocimo, Domenick A.; Haldar, Saptarsi M.; Jain, Mukesh K.; Gillingwater, Thomas H.; Claus, Peter; Kothary, Rashmi; Wood, Matthew J.A.; Bowerman, Melissa
Authors
Marc-Olivier Deguise
Katharina E. Meijboom
Corinne A. Betts
Nina Ahlskog
Tirsa L.E. van Westering
Gareth Hazell
Emily McFall
Anna Kordala
Suzan M. Hammond
Frank Abendroth
Lyndsay M. Murray
Hannah K. Shorrock
Domenick A. Prosdocimo
Saptarsi M. Haldar
Mukesh K. Jain
Thomas H. Gillingwater
Peter Claus
Rashmi Kothary
Matthew J.A. Wood
Melissa Bowerman m.bowerman@keele.ac.uk
Abstract
The circadian glucocorticoid-Krüppel-like factor 15-branched-chain amino acid (GC-KLF15-BCAA) signaling pathway is a key regulatory axis in muscle, whose imbalance has wide-reaching effects on metabolic homeostasis. Spinal muscular atrophy (SMA) is a neuromuscular disorder also characterized by intrinsic muscle pathologies, metabolic abnormalities and disrupted sleep patterns, which can influence or be influenced by circadian regulatory networks that control behavioral and metabolic rhythms. We therefore set out to investigate the contribution of the GC-KLF15-BCAA pathway in SMA pathophysiology of Taiwanese Smn-/-;SMN2 and Smn2B/- mouse models. We thus uncover substantial dysregulation of GC-KLF15-BCAA diurnal rhythmicity in serum, skeletal muscle and metabolic tissues of SMA mice. Importantly, modulating the components of the GC-KLF15-BCAA pathway via pharmacological (prednisolone), genetic (muscle-specific Klf15 overexpression) and dietary (BCAA supplementation) interventions significantly improves disease phenotypes in SMA mice. Our study highlights the GC-KLF15-BCAA pathway as a contributor to SMA pathogenesis and provides several treatment avenues to alleviate peripheral manifestations of the disease. The therapeutic potential of targeting metabolic perturbations by diet and commercially available drugs could have a broader implementation across other neuromuscular and metabolic disorders characterized by altered GC-KLF15-BCAA signaling.
Citation
Walter, L. M., Deguise, M., Meijboom, K. E., Betts, C. A., Ahlskog, N., van Westering, T. L., …Bowerman, M. (2018). Interventions Targeting Glucocorticoid-Krüppel-like Factor 15-Branched-Chain Amino Acid Signaling Improve Disease Phenotypes in Spinal Muscular Atrophy Mice. EBioMedicine, 226-242. https://doi.org/10.1016/j.ebiom.2018.04.024
Acceptance Date | Apr 26, 2018 |
---|---|
Publication Date | May 1, 2018 |
Journal | EBioMedicine |
Publisher | Elsevier |
Pages | 226-242 |
DOI | https://doi.org/10.1016/j.ebiom.2018.04.024 |
Keywords | spinal muscular atrophy, KLF15, glucocorticoids, branched-chain amino acids, metabolism, therapy |
Publisher URL | https://doi.org/10.1016/j.ebiom.2018.04.024 |
Files
KLF15_EBioMedicine_Revised_April 25th 2018.pdf
(581 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by-nc-nd/4.0/
You might also like
Dystrophin involvement in peripheral circadian SRF signalling
(2021)
Journal Article
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search